Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/25/2869581/0/en/Aquestive-Therapeutics-to-Report-First-Quarter-2024-Financial-Results-and-Recent-Business-Highlights-on-May-7-and-Host-Conference-Call-on-May-8-at-8-00-a-m-ET.html
https://www.globenewswire.com/news-release/2024/04/12/2862377/0/en/Aquestive-Therapeutics-to-Present-Crossover-Study-Data-for-Libervant-diazepam-Buccal-Film-at-76th-Annual-Meeting-of-the-American-Academy-of-Neurology.html
https://www.globenewswire.com/news-release/2024/04/01/2855154/0/en/Aquestive-Therapeutics-Strengthens-Board-of-Directors-with-Experienced-Biotech-Executive.html
https://www.globenewswire.com/news-release/2024/03/25/2851585/0/en/Aquestive-Therapeutics-Announces-Closing-of-Underwritten-Public-Offering-of-Common-Stock.html
https://www.globenewswire.com/news-release/2024/03/20/2849064/0/en/Aquestive-Therapeutics-Announces-Pricing-of-75-Million-Underwritten-Public-Offering-of-Common-Stock.html
https://www.globenewswire.com/news-release/2024/03/19/2848956/0/en/Aquestive-Therapeutics-Announces-Proposed-Public-Offering-of-Common-Stock.html
https://www.globenewswire.com//news-release/2024/03/14/2846751/0/en/Aquestive-Therapeutics-Announces-Pivotal-Study-for-Anaphylm-epinephrine-Sublingual-Film-Successfully-Meets-Primary-and-Secondary-Endpoints-and-Provides-Clinical-Development-Update-.html
https://www.globenewswire.com//news-release/2024/03/05/2840981/0/en/Aquestive-Therapeutics-Reports-Full-Year-2023-Financial-Results-and-Provides-Business-Update.html
https://www.globenewswire.com//news-release/2024/02/21/2832708/0/en/Aquestive-Therapeutics-to-Report-Fourth-Quarter-2023-Financial-Results-and-Recent-Business-Highlights-on-March-5-and-Host-Conference-Call-on-March-6-at-8-00-a-m-ET.html
https://www.globenewswire.com//news-release/2024/02/15/2829938/0/en/Aquestive-Therapeutics-to-Present-Anaphylm-epinephrine-Sublingual-Film-Pharmacokinetic-and-Pharmacodynamic-Data-at-the-2024-AAAAI-Annual-Meeting.html